Conference Scene: 2nd Cancer Epigenetics Conference

• Filippakopoulos P , PicaudS, MangosM et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149(1) , 214–231 (2012).
   PubMed Web of Science ®Google Scholar
• Muller S , FilippakopoulosP, KnappS. Bromodomains as therapeutic targets. Expert Rev. Mol. Med.13 , e29 (2011).
   PubMed Web of Science ®Google Scholar
• Hewings DS , WangM, PhilpottM et al. 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. J. Med. Chem. 54(19) , 6761–6770 (2011).
   PubMed Web of Science ®Google Scholar
• Hewings DS , RooneyTP, JenningsLE et al. Progress in the development and application of small molecule inhibitors of bromodomain–acetyl–lysine interactions. J. Med. Chem. 55(22) , 9393–9413 (2012).
   PubMed Web of Science ®Google Scholar
• Bryant B . Chromatin computation. PLoS ONE7(5) , e35703 (2012).
   PubMedGoogle Scholar
• Prinjha RK , WitheringtonJ, LeeK. Place your BETs: the therapeutic potential of bromodomains. Trends Pharmacol. Sci.33(3) , 146–153 (2012).
   PubMed Web of Science ®Google Scholar
• Chung CW , CosteH, WhiteJH et al. Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J. Med. Chem. 54(11) , 3827–3838 (2011).
   PubMed Web of Science ®Google Scholar
• Dawson MA , PrinjhaRK, DittmannA et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478(7370) , 529–533 (2011).
   PubMed Web of Science ®Google Scholar
• Zuber J , ShiJ, WangE et al. RNAi screen identifies BRD4 as a therapeutic target in acute myeloid leukaemia. Nature 478(7370) , 524–528 (2011).
   PubMed Web of Science ®Google Scholar
• Nicodeme E , JeffreyKL, SchaeferU et al. Suppression of inflammation by a synthetic histone mimic. Nature 468(7327) , 1119–1123 (2010).
   PubMed Web of Science ®Google Scholar
• Bisgrove DA , MahmoudiT, HenkleinP, VerdinE. Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proc. Natl Acad. Sci. USA104(34) , 13690–13695 (2007).
   PubMed Web of Science ®Google Scholar
• Marazzi I , HoJS, KimJ et al. Suppression of the antiviral response by an influenza histone mimic. Nature 483(7390) , 428–433 (2012).
   PubMed Web of Science ®Google Scholar
• Delmore JE , IssaGC, LemieuxME et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146(6) , 904–917 (2011).
   PubMed Web of Science ®Google Scholar
• Schwartz BE , HoferMD, LemieuxME et al. Differentiation of nut midline carcinoma by epigenomic reprogramming. Cancer Res. 71(7) , 2686–2696 (2011).
   PubMed Web of Science ®Google Scholar
• Herrmann H , BlattK, ShiJ et al. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML. Oncotarget 3(12) , 1588–1599 (2012).
   PubMed Web of Science ®Google Scholar
• Matzuk MM , MckeownMR, FilippakopoulosP et al. Small-molecule inhibition of BRDT for male contraception. Cell 150(4) , 673–684 (2012).
   PubMed Web of Science ®Google Scholar
• Sharma SV , LeeDY, LiB et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141(1) , 69–80 (2010).
   PubMed Web of Science ®Google Scholar
• Mertz JA , ConeryAR, BryantBM et al. Targeting myc dependence in cancer by inhibiting bet bromodomains. Proc. Natl Acad. Sci. USA 108(40) , 16669–16674 (2011).
   PubMed Web of Science ®Google Scholar
• Munteanu B , Von Reitzenstein C, Hansch GM, Meyer B, Hopf C. Sensitive, robust and automated protein analysis of cell differentiation and of primary human blood cells by intact cell MALDI mass spectrometry biotyping. Anal. Bioanal. Chem.404(8) , 2277–2286 (2012).
   PubMed Web of Science ®Google Scholar
• Heltweg B , GatbontonT, SchulerAD et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res. 66(8) , 4368–4377 (2006).
   PubMed Web of Science ®Google Scholar
• Copeland RA , OlhavaEJ, ScottMP. Targeting epigenetic enzymes for drug discovery. Curr. Opin Chem. Biol.14(4) , 505–510 (2010).
   PubMed Web of Science ®Google Scholar
• Copeland RA , MoyerMP, RichonVM. Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics. Oncogene32(8) , 939–946 (2012).
   PubMed Web of Science ®Google Scholar
• Majer CR , JinL, ScottMP et al. A687V EZH2 is a gain-of-function mutation found in lymphoma patients. FEBS Lett. 586(19) , 3448–3451 (2012).
   PubMed Web of Science ®Google Scholar
• Cosgrove MS , PatelA. Mixed lineage leukemia: a structure–function perspective of the MLL1 protein. FEBS J.277(8) , 1832–1842 (2010).
   PubMed Web of Science ®Google Scholar
• Dharmarajan V , LeeJH, PatelA, SkalnikDG, CosgroveMS. Structural basis for WDR5 interaction (win) motif recognition in human SET1 family histone methyltransferases. J. Biol. Chem.287(33) , 27275–27289 (2012).
   PubMed Web of Science ®Google Scholar
• Kawamura A , TumberA, RoseNR et al. Development of homogeneous luminescence assays for histone demethylase catalysis and binding. Anal. Biochem. 404(1) , 86–93 (2010).
   PubMed Web of Science ®Google Scholar
• King ON , LiXS, SakuraiM et al. Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors. PLoS ONE 5(11) , e15535 (2010).
   PubMed Web of Science ®Google Scholar
• Kar S , DebM, SenguptaD et al. An insight into the various regulatory mechanisms modulating human DNA methyltransferase 1 stability and function. Epigenetics 7(9) , 994–1007 (2012).
   PubMed Web of Science ®Google Scholar
• Schenk T , ChenWC, GollnerS et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nature Med. 18(4) , 605–611 (2012).
   PubMed Web of Science ®Google Scholar
• Sinha SH , OwensEA, FengY et al. Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents. Eur. J. Med. Chem. 54 , 647–659 (2012).
   PubMed Web of Science ®Google Scholar
• Al-Dhaheri M , WuJ, SklirisGP et al. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells. Cancer Res. 71(6) , 2118–2128 (2011).
   PubMed Web of Science ®Google Scholar
• Masch A , ZerweckJ, ReimerU, WenschuhH, SchutkowskiM. Antibody signatures defined by high-content peptide microarray analysis. Methods Mol. Biol.669 , 161–172 (2010).
   PubMedGoogle Scholar
• Houseman EA , AccomandoWP, KoestlerDC et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13 , 86 (2012).
   PubMed Web of Science ®Google Scholar
• Wiencke JK , AccomandoWP, ZhengS et al. Epigenetic biomarkers of T-cells in human glioma. Epigenetics 7(12) , 1391–1402 (2012).
   PubMed Web of Science ®Google Scholar
• Accomando WP , WienckeJK, HousemanEA et al. Decreased nk cells in patients with head and neck cancer determined in archival DNA. Clin. Cancer Res. 18(22) , 6147–6154 (2012).
   PubMed Web of Science ®Google Scholar
• Devos T , TetznerR, ModelF et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin. Chem. 55(7) , 1337–1346 (2009).
   PubMed Web of Science ®Google Scholar
• Kinney SM , ChinHG, VaisvilaR et al. Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. J. Biol. Chem. 286(28) , 24685–24693 (2011).
   PubMed Web of Science ®Google Scholar
• Kinney SR , PradhanS. Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer. Adv. Exp. Med. Biol.754 , 57–79 (2013).
   PubMed Web of Science ®Google Scholar
• Esteve PO , ChangY, SamaranayakeM et al. A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability. Nat. Struct. Mol. Biol. 18(1) , 42–48 (2011).
   PubMed Web of Science ®Google Scholar
• Kinney SR , PradhanS. Regulation of expression and activity of DNA (cytosine-5) methyltransferases in mammalian cells. Prog. Mol. Biol. Transl Sci.101 , 311–333 (2011).
   PubMed Web of Science ®Google Scholar
• Cohen-Karni D , XuD, AponeL et al. The mspji family of modification-dependent restriction endonucleases for epigenetic studies. Proc. Natl Acad. Sci. USA 108(27) , 11040–11045 (2011).
   PubMed Web of Science ®Google Scholar
• Ferraiuolo MA , SanyalA, NaumovaN, DekkerJ, DostieJ. From cells to chromatin: capturing snapshots of genome organization with 5c technology. Methods58(3) , 255–267 (2012).
   PubMed Web of Science ®Google Scholar
• Naumova N , SmithEM, ZhanY, DekkerJ. Analysis of long-range chromatin interactions using chromosome conformation capture. Methods58(3) , 192–203 (2012).
   PubMed Web of Science ®Google Scholar
• Magistri M , FaghihiMA, St Laurent G 3rd, Wahlestedt C. Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet.28(8) , 389–396 (2012).
   PubMed Web of Science ®Google Scholar
• Smith CL , BoltonA, NguyenG. Genomic and epigenomic instability, fragile sites, schizophrenia and autism. Curr. Genomics11(6) , 447–469 (2010).
   PubMed Web of Science ®Google Scholar

▪ Websites

• The Structural Genomics Consortium. www.thesgc.org
   Google Scholar
• ENCODE. http://encodeproject.org/ENCODE/
   Google Scholar
• FANTOM. http://fantom.gsc.riken.jp/
   Google Scholar
• Smith CL, Grace K. A paradigm shift in diagnosing and treating ASD patients: autism is a treatable medical and metabolic disease with behavioral components (2012). www.scribd.com/doc/115501296/A-Paradigm-Shift-in-Diagnosing-and-Treating-ASD-patients-Autism-is-a-Treatable-Medical-and-Metabolic-Disease-with-Behavioral-Components
   Google Scholar

▪ Patent

• Miyoshi S, Ooike S, Iwata K, Hikawa H, Sugaraha K. Antitumor agents. International patent No. PCT/JP2008/073864 (WO/2009/084693) (2009).
   Google Scholar